Workflow
盐酸特拉唑嗪
icon
Search documents
中瑞药业因安全生产违法被罚
Qi Lu Wan Bao· 2025-08-25 08:21
Core Viewpoint - Tianjin Zhongrui Pharmaceutical Co., Ltd. was fined 15,000 RMB due to safety production violations, specifically for the installation of safety equipment not meeting national standards [1][2]. Company Information - Tianjin Zhongrui Pharmaceutical Co., Ltd. is a high-tech enterprise established in March 2004, with a registered capital of 26 million RMB [2]. - The company specializes in the production of chemical raw materials, pharmaceutical excipients, and food additives, with key products including niacin, niacinamide, and hydrochloride drugs [2]. Regulatory Action - The fine was imposed by the Wuqing District Emergency Management Bureau, citing violations of the Production Safety Law of the People's Republic of China [2]. - The penalty decision was documented under the administrative penalty decision number (津武)应急罚《2025》危-04号 [2].